News | October 16, 2025
Syngene International invests in peptide laboratory in Bengaluru
Accelerating hit-to-lead timelines, and strengthening end-to-end drug discovery and development services
Accelerating hit-to-lead timelines, and strengthening end-to-end drug discovery and development services
The new line features advanced isolator technology to deliver enhanced sterility assurance, throughput and operational precision
The collaboration combines the extensive CMC expertise of Sai Life Sciences in API development, Agility Life Sciences in formulation development, and Centrix Pharma Solutions in drug product development and clinical manufacturing
Early stage projects of up to Rs. 9 crore eligible for up to Rs. 5 crore assistance and later stage projects of up to Rs. 285 crore eligible for up to Rs. 100 crore assistance
Marks first international filing for Evofem’s single-dose oral treatment
82,514 sq ft facility to host up to 15 biotech companies, fueling the development of next-generation medicines
BIL also holds an option to increase its equity stake by an additional 15%
Alkem's Pertuza is an affordable, indigenously-developed and manufactured biosimilar of pertuzumab
Subscribe To Our Newsletter & Stay Updated
